Interventional Therapy For Pancreatic Cancer Is A Win-Win Choice For Patients
Pancreatic cancer is a very malignant tumor, and its mortality to morbidity ratio is 0.99:1. Because there are often no symptoms in the early onset, many patients are diagnosed at an advanced stage. The incidence rate increases with age and cases are mainly between the ages of 60 and 80, and it is more common in men than women.
Over the years, the incidence has been on the rise, and becoming an important disease threatening human health. Because pancreatic cancer is often found at an advanced stage, only 15% of patients can be surgically removed. Pancreatic cancer is biologically different from other cancers in that it is not sensitive to conventional chemotherapy and radiation, Therefore, pancreatic cancer is often called "the king of cancer" by doctors and patients, and giving up treatment has become a helpless choice.
In fact, at this time there is a very good choice, not only to achieve the effect of chemotherapy, but also to avoid the suffering of chemotherapy, that is the interventional treatment.
The Interventional Group of Chinese Society of Radiology made detailed guidelines for the interventional treatment of unresectable pancreatic cancer last year, and the efficacy of transarterial chemotherapy had been highly affirmed. Clinical studies have shown that interventional therapy has achieved remarkable results in improving pancreatic cancer-related symptoms, prolonging survival, reducing liver metastases, and treatment after liver metastases.
How does interventional therapy for pancreatic cancer work?
A relatively simple method is femoral artery puncture intubation, placing the catheter into the pancreatic artery blood supply, and injecting the anti-tumor drug through the catheter to the lesion, which makes the local tumor tissues have a higher drug concentration for a long time. It prolongs the contact time of the drug to the tumor tissue in order to achieve the effect of killing tumor cells. At the same time, the drug concentration of other organs in the body is very low, and the patient's side effects caused by chemotherapy are very small.
If it is possible, doctors can place one end of the catheter in the blood vessels of pancreatic cancer and the other end is placed under the skin in the chest. When anti-tumor drugs are needed, they can be injected through this catheter.
Interventional therapy can not only treat pancreatic cancer itself, but also has significant advantages in managing pancreatic cancer-related clinical symptoms. Either way, it is a minimally invasive surgery that does not require high age and physical conditions. It is suitable for all types of pancreatic cancer patients who cannot be surgically resected.
